These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35945062)

  • 21. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
    Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G
    J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients.
    Buckley BJR; Harrison SL; Fazio-Eynullayeva E; Underhill P; Lane DA; Lip GYH
    Eur J Clin Invest; 2021 Nov; 51(11):e13679. PubMed ID: 34516657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocarditis and related complications of SARS-CoV-2 infection.
    Rahman A
    Aust J Gen Pract; 2022 Sep; 51(9):661-665. PubMed ID: 36045621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus disease 2019 and cardiovascular diseases: collateral damage?
    Pillai A; Lawson B
    Curr Opin Anaesthesiol; 2022 Feb; 35(1):5-11. PubMed ID: 34839301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents.
    Schauer J; Buddhe S; Colyer J; Sagiv E; Law Y; Mallenahalli Chikkabyrappa S; Portman MA
    J Pediatr; 2021 Nov; 238():317-320. PubMed ID: 34228985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Manifestations of COVID-19 Infection.
    Magadum A; Kishore R
    Cells; 2020 Nov; 9(11):. PubMed ID: 33228225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
    Li YE; Wang S; Reiter RJ; Ren J
    Int J Infect Dis; 2022 Nov; 124():1-10. PubMed ID: 36075372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection.
    Al-Kindi S; Zidar DA
    Transl Res; 2022 Mar; 241():25-40. PubMed ID: 34780967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology].
    Sinagra G; Porcari A; Merlo M; Fabris E; Imazio M; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Spaccarotella C; Filardi PP; Indolfi C
    G Ital Cardiol (Rome); 2022 Jun; 23(6):408-413. PubMed ID: 35674028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.
    Haaf P; Kuster GM; Mueller C; Berger CT; Monney P; Burger P; Stämpfli SF; Attenhofer Jost CH; Zellweger MJ; Osswald S; Donner BC; Koestner SC; Tanner FC
    Swiss Med Wkly; 2021 Oct; 151():w30087. PubMed ID: 34668687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
    Groß S; Jahn C; Cushman S; Bär C; Thum T
    J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
    Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
    Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination: A Pragmatic Narrative Review to Guide Clinical Practice.
    Holland DJ; Blazak PL; Martin J; Broom J; Poulter RS; Stanton T
    Heart Lung Circ; 2022 Jul; 31(7):924-933. PubMed ID: 35398005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Liu PP; Blet A; Smyth D; Li H
    Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review on Cardiorespiratory Complications after SARS-CoV-2 Infection in Young Adult Healthy Athletes.
    Romagnoli S; Sbrollini A; Marcantoni I; Morettini M; Burattini L
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes.
    Raukar NP; Cooper LT
    Sports Health; 2021 Mar; 13(2):145-148. PubMed ID: 33201768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.
    Yap J; Tham MY; Poh J; Toh D; Chan CL; Lim TW; Lim SL; Chia YW; Lim YT; Choo J; Ding ZP; Foo LL; Kuo S; Lau YH; Lee A; Yeo KK
    Ann Acad Med Singap; 2022 Feb; 51(2):96-100. PubMed ID: 35224605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.